サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1182035

サル痘ワクチンと治療の世界市場調査＆予測：製品別（ワクチン、薬剤、ワクチン免疫グロブリン）、性別、投与経路別、エンドユーザー別、地域分析、2022-2029年

Global Monkeypox Vaccine and Treatment Market Size study & Forecast, by Product (Vaccine, Drugs, Vaccinia Immune Globulin ) by Gender, by Route of Administration, by End Use and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
サル痘ワクチンと治療の世界市場調査＆予測：製品別（ワクチン、薬剤、ワクチン免疫グロブリン）、性別、投与経路別、エンドユーザー別、地域分析、2022-2029年
出版日: 2023年01月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のサル痘ワクチン・治療市場は、2021年に約7,834万米ドルと評価され、予測期間2022-2029年には10.2%以上で成長すると予想されています。

ポックスウイルス科オルソポックスウイルス属の一種であるサル痘ウイルスは、サル痘の元凶です。天然痘撲滅作戦で採用されたサル痘ワクチンは、その病気からの予防効果もあっています。サル痘ワクチン・治療市場は、サル痘の感染率の増加や、サル痘の発生を防ぐための政府の高い取り組みなどの要因から拡大しています。しかし、ワクチンや治療に伴う副作用が市場成長を阻害する可能性があります。

例えば、米国疾病対策予防センターの情報によると、2022年8月9日までに世界で確認されたサル痘の症例は31,800件で、そのうち31,425件はこれまでサル痘の報告がなかった国々で発生していると推定されています。一方、過去にサル痘の感染が確認された国は375カ国です。さらに、2022年4月から6月にかけて、世界16カ国で発生したサル痘の感染者の98％が、男性と性交渉を持つ男性やLGBTグループであることが、New England Journal of Medicine誌に掲載された報告により明らかになっています。このように、世界中でサル痘病の有病率が上昇していることは、市場の成長に寄与しています。さらに、ワクチン開発における技術的進歩の高まりや、研究や活動のための政府のイニシアティブの高まりは、市場の有利な成長を生み出しています。しかし、サル痘ワクチンと治療の副作用は、2022年から2029年の予測期間を通じて、市場の成長を抑制します。

世界のサル痘ワクチンおよび治療市場調査のために考慮された主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、および世界のその他の地域が含まれています。これらの地域のうち、北米は、疾患の有病率の上昇などの要因により、2021年に最高のシェアを保持しており、研究開発への政府投資の増加は、市場で有利な成長を提供すると予測されています。アジア太平洋地域は、サルモネラ菌感染数の増加やワクチン開発のための研究開発の増加といった要因から、最も速い速度で市場成長を示すと予測されています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的側面と量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメンテーション市場の推定・予測、2019年～2029年
    • サル痘ワクチンと治療薬市場：地域別、2019年～2029年
    • サル痘ワクチンと治療薬市場：製品別、2019年～2029年
    • サル痘ワクチンと治療薬市場：男女別、2019-2029年
    • サル痘ワクチンと治療薬市場：投与経路別、2019年-2029年
    • サル痘ワクチンと治療薬市場：エンドユース別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 サル痘ワクチンと治療薬の世界市場の定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 世界のサル痘ワクチンと治療薬市場力学

  • サル痘ワクチンと治療薬市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • サル痘の発生率および有病率の増加
      • サル痘の発生に対抗するための政府の取り組み
    • 市場の課題
      • ワクチンおよび治療に関連する副作用
    • 市場機会
      • ワクチン開発活動の進展

第4章 サル痘ワクチンと治療の世界市場、産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップ投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 サル痘ワクチンと治療の世界市場：製品別

  • 市場スナップショット
  • サル痘ワクチンと治療の世界市場：製品別、性能-ポテンシャル分析
  • サル痘ワクチンと治療の世界市場、製品別推定・予測2019～2029年
  • サル痘ワクチンと治療法市場、サブセグメント分析
    • ワクチン
    • 薬剤
    • ワクシニア免疫グロブリン（VIG）

第7章：サル痘ワクチン・治療薬の世界市場：男女別

  • 市場スナップショット
  • サル痘ワクチンと治療の世界市場：性別、性能、潜在能力分析
  • サル痘ワクチン・治療の世界市場、性別ごとの推定・予測（2019-2029年
  • サル痘ワクチンと治療の市場、サブセグメント分析
    • 男性
    • 女性
    • その他

第8章 サル痘ワクチンと治療の世界市場：投与経路別

  • 市場スナップショット
  • サル痘ワクチンと治療の世界市場：投与ルート別、実績-ポテンシャル分析
  • サル痘ワクチンと治療の世界市場、投与ルート別推定・予測2019-2029年
  • サル痘ワクチンと治療薬市場、サブセグメント分析
    • 経口剤
    • 注射剤

第9章 サル痘ワクチンと治療の世界市場：エンドユーザー別

  • 市場スナップショット
  • サル痘ワクチンと治療の世界市場：エンドユース別実績・潜在能力分析
  • サル痘ワクチンと治療の世界市場、エンドユース別推定・予測2019～2029年
  • サル痘ワクチンおよび治療市場、サブセグメント分析
    • 病院
    • 専門クリニック
    • その他

第10章 サル痘ワクチンと治療の世界市場：地域別分析

  • サル痘ワクチンと治療市場：地域別市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2019年～2029年
      • 男女別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019-2029年
    • カナダ
  • 欧州のサル痘ワクチン・治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域のサル痘ワクチン・治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのサル痘ワクチンと治療薬市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第11章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Bavarian Nordic
      • 主要情報
      • 概要
      • 財務情報（データの入手状況により異なります）
      • 製品概要
      • 最近の動向
    • SIGA Technologies
    • Chimerix
    • Emergent
    • Gilead Sciences, Inc.
    • Sanofi SA
    • Emcure Pharma
    • Jinan Jinda Pharmaceutical Chemistry Co., Ltd
    • Reliance Life Sciences
    • Haffkine Institute

第12章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Monkeypox Vaccine and Treatment Market, report scope
  • TABLE 2. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Product 2019-2029 (USD Million)
  • TABLE 4. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Gender 2019-2029 (USD Million)
  • TABLE 5. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Million)
  • TABLE 6. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by End Use 2019-2029 (USD Million)
  • TABLE 7. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 18. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 21. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 24. UK Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. UK Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 27. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 30. France Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. France Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 33. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 36. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 39. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 42. China Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. China Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 45. India Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. India Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 48. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 51. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 54. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 60. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 63. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 66. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 69. Row Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. Row Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 71. List of secondary sources, used in the study of global Monkeypox Vaccine and Treatment Market
  • TABLE 72. List of primary sources, used in the study of global Monkeypox Vaccine and Treatment Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Monkeypox Vaccine and Treatment Market, research methodology
  • FIG 2. Global Monkeypox Vaccine and Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Monkeypox Vaccine and Treatment Market, key trends 2021
  • FIG 5. Global Monkeypox Vaccine and Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Monkeypox Vaccine and Treatment Market, porters 5 force model
  • FIG 7. Global Monkeypox Vaccine and Treatment Market, pest analysis
  • FIG 8. Global Monkeypox Vaccine and Treatment Market, value chain analysis
  • FIG 9. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Monkeypox Vaccine and Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 19. Global Monkeypox Vaccine and Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Monkeypox Vaccine and Treatment Market is valued at approximately USD 78.34 million in 2021 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2022-2029. The monkeypox virus, a species of the Orthopoxviral genus in the family Poxviridae, is the culprit behind monkeypox. The monkeypox vaccines employed in the smallpox eradication operation also offered protection from that disease. The Monkeypox Vaccine and Treatment market is expanding because of factors such an as Increase in the prevalence of monkeypox infection, and high government initiatives to combat outbreaks of monkeypox. However, Side effects associated with the vaccine and treatment may halt market growth.

For instance, according to information from the Centers for Disease Control and Prevention, there are estimated to be 31,800 confirmed cases of monkeypox worldwide through August 9, 2022, of which 31,425 are in nations that have never previously reported monkeypox. While there are 375 nations where monkeypox has previously been documented. Additionally, it was discovered that between April and June 2022, 98% of the monkeypox infections in 16 nations worldwide were in males who have sex with men and LGBT groups, per a report published in the New England Journal of Medicine. Thus, the rising prevalence of monkey pox disease across the globe is catering for the growth of the market. Furthermore, rising technological advancement in the development of vaccines and rising government initiatives for research and activities are creating lucrative growth in the market. However, the side effects of the Monkeypox Vaccine and Treatment stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Monkeypox Vaccine and Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Among these regions, North America holds the highest share in the year 2021 owing to factors such as the rising prevalence of disease, and rising government investment in research and development is anticipated to provide lucrative growth in the market. Asia Pacific is projected to witness the fastest region owing to factors such as rising number of monkeypox infections and increasing research and development for developing vaccines driving the growth of market.

Major market players included in this report are:

Bavarian Nordic

SIGA Technologies

Chimerix Inc

Emergent

Gilead Sciences, Inc.

Sanofi SA

Emcure Pharma Company

Jinan Jinda Pharmaceutical Chemistry Co., Ltd

Reliance Life Sciences

Haffkine Institute for training research and testing

Recent Developments in the Market:

  • In February 2022, Bavarian Nordic A/S announced the contract of 2.5 million doses of an additional order of JYNNEOS from the U.S.
  • In Aug 2022, the tecovirimat (oral) by SIGA was licenced by the U.K. for the management of monkeypox and other indications in adults and children with body weights greater than 13 kg. The medication has also been given the go-ahead to treat monkeypox sickness in other European nations.

Global Monkeypox Vaccine and Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Gender, Route of Administration, End Use, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Vaccine

Drugs

Vaccinia Immune Globulin (VIG)

By Gender:

Male

Female

Others

Route of Administration:

Oral

Injectables

By End Use:

Hospitals

Specialty ClinicsOthers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Monkeypox Vaccine and Treatment Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Monkeypox Vaccine and Treatment Market, by Product, 2019-2029 (USD Million)
    • 1.2.3. Monkeypox Vaccine and Treatment Market, by Gender, 2019-2029 (USD Million)
    • 1.2.4. Monkeypox Vaccine and Treatment Market, by Route of Administration, 2019-2029 (USD Million)
    • 1.2.5. Monkeypox Vaccine and Treatment Market, by End Use, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Monkeypox Vaccine and Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Monkeypox Vaccine and Treatment Market Dynamics

  • 3.1. Monkeypox Vaccine and Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence and prevalence of Monkeypox
      • 3.1.1.2. Government initiatives to combat an outbreak of monkeypox
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with the vaccine and treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in vaccine development activities

Chapter 4. Global Monkeypox Vaccine and Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Monkeypox Vaccine and Treatment Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Monkeypox Vaccine and Treatment Market by Product, Performance - Potential Analysis
  • 6.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Product 2019-2029 (USD Million)
  • 6.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 6.4.1. Vaccine
    • 6.4.2. Drugs
    • 6.4.3. Vaccinia Immune Globulin (VIG)

Chapter 7. Global Monkeypox Vaccine and Treatment Market, by Gender

  • 7.1. Market Snapshot
  • 7.2. Global Monkeypox Vaccine and Treatment Market by Gender, Performance - Potential Analysis
  • 7.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Gender 2019-2029 (USD Million)
  • 7.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 7.4.1. Male
    • 7.4.2. Female
    • 7.4.3. Others

Chapter 8. Global Monkeypox Vaccine and Treatment Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Monkeypox Vaccine and Treatment Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Million)
  • 8.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injectables

Chapter 9. Global Monkeypox Vaccine and Treatment Market, by End Use

  • 9.1. Market Snapshot
  • 9.2. Global Monkeypox Vaccine and Treatment Market by End Use, Performance - Potential Analysis
  • 9.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
  • 9.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 9.4.1. Hospitals
    • 9.4.2. Specialty Clinics
    • 9.4.3. Others

Chapter 10. Global Monkeypox Vaccine and Treatment Market, Regional Analysis

  • 10.1. Monkeypox Vaccine and Treatment Market, Regional Market Snapshot
  • 10.2. North America Monkeypox Vaccine and Treatment Market
    • 10.2.1. U.S. Monkeypox Vaccine and Treatment Market
      • 10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 10.2.1.2. Gender breakdown estimates & forecasts, 2019-2029
      • 10.2.1.3. ijkl breakdown estimates & forecasts, 2019-2029
      • 10.2.1.4. End Use breakdown estimates & forecasts, 2019-2029
    • 10.2.2. Canada Monkeypox Vaccine and Treatment Market
  • 10.3. Europe Monkeypox Vaccine and Treatment Market Snapshot
    • 10.3.1. U.K. Monkeypox Vaccine and Treatment Market
    • 10.3.2. Germany Monkeypox Vaccine and Treatment Market
    • 10.3.3. France Monkeypox Vaccine and Treatment Market
    • 10.3.4. Spain Monkeypox Vaccine and Treatment Market
    • 10.3.5. Italy Monkeypox Vaccine and Treatment Market
    • 10.3.6. Rest of Europe Monkeypox Vaccine and Treatment Market
  • 10.4. Asia-Pacific Monkeypox Vaccine and Treatment Market Snapshot
    • 10.4.1. China Monkeypox Vaccine and Treatment Market
    • 10.4.2. India Monkeypox Vaccine and Treatment Market
    • 10.4.3. Japan Monkeypox Vaccine and Treatment Market
    • 10.4.4. Australia Monkeypox Vaccine and Treatment Market
    • 10.4.5. South Korea Monkeypox Vaccine and Treatment Market
    • 10.4.6. Rest of Asia Pacific Monkeypox Vaccine and Treatment Market
  • 10.5. Latin America Monkeypox Vaccine and Treatment Market Snapshot
    • 10.5.1. Brazil Monkeypox Vaccine and Treatment Market
    • 10.5.2. Mexico Monkeypox Vaccine and Treatment Market
  • 10.6. Rest of The World Monkeypox Vaccine and Treatment Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Bavarian Nordic
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. SIGA Technologies
    • 11.2.3. Chimerix
    • 11.2.4. Emergent
    • 11.2.5. Gilead Sciences, Inc.
    • 11.2.6. Sanofi SA
    • 11.2.7. Emcure Pharma
    • 11.2.8. Jinan Jinda Pharmaceutical Chemistry Co., Ltd
    • 11.2.9. Reliance Life Sciences
    • 11.2.10. Haffkine Institute

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption